Provide expert scientific review so that compelling technologies are funded that will combat disease and improve human life. Review NIH SBIR grants and provide written feedback that follows the SBIR study section format, with a more detailed and diligent feedback.Primary experience sitting on SBIR review panels reviewing grants, including NIH SBIR proposals, and NSF proposals. Perform gap analysis by identifying weaknesses and strengths, provided approaches, and/or tactics that could address these weaknesses.

Research and Development for creating solutions to replace preservatives and biocides with an equally effective, safe, and sustainable biological solution.

• Led and managed a cross-functional team of engineers, scientists, and clinicians. • Developed biological assays and high-through put drug screening for hepatoxicity of DILI compounds (Co-Investigator NIH Grant).• Optimized and characterized assays for high-content imaging and high-content data analysis for product validation. • Developed and applied cell and molecular biology techniques on human-on-a-plate and microfluidic exposure chambers.• Designed and implemented prototypes for maintenance and functional testing of multi-organ 2D and 3D hepatic tissues. (Co-Investigator NIH Grant).• Optimized and characterized corrosion-resistant biological assay systems for Environmental Protection Agency (EPA). (Co-Investigator NIH Grant).• Developed reliable and user-friendly SOPs for purpose of customer ease and repeatability. • Authored and reviewed R&D grants (NIH, EPA, and NSF), journal articles, and technical reports. • Responsible for talent acquisition for the scientific team, including new hire training, career development, employee dialogues and compensation. • Undertook program and client management functions and interfaced with sub-contractors and consultants.• Completed CRO assignments and successful RRCA for pharmaceutical companies.

• Developed cell culture models to evaluate interaction between ovarian cancer cells and adipocytes in tumor microenvironment.• Developed novel pre-clinical models to elucidate the disease-association and functions of SPARC in the bladder cancer.• Identified SPARC-associated biomarkers utilizing gene expression analysis that can be exploited to develop diagnostic, prognostic and/or therapeutic strategies. • Managed, mentored, and led research associates and graduate students.

• Bioluminescent cell line development for substrate free non-invasive optical spectroscopic imaging. • Tested efficacy of novel chemotherapeutic drugs for treatment of urinary bladder cancer and to analyze molecular mechanisms of drug action. • Designed, developed, and implemented subcutaneous mouse models of urinary bladder cancer for in vivo imaging of tumor growth, metastasis and recurrence. • Isolated and generated bladder tumor cell lines for ex-vivo imaging and drug response studies. • Mentored and supervised graduate and undergraduate students in various research techniques. • Maintained lab instrumentation and equipment and assisted the advisor in day-to-day operations of the lab.